Cis-platinum: a new anticancer agent.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  British medical journal

• Publication date

  1979-06-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1136/bmj.1.6179.1689PMID 380759PMCID PMC1599237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of cis-platinum in solid-tumor therapy.

  1979cited by this paper
• Long term effect of Cis‐Diamminedichloride platinum (CDDP) on renal function and structure in man

  1978cited by this paper
• 24‐Hour infusion of cis‐platinum in head and neck cancers

  1978cited by this paper
• Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.

  1978cited by this paper
• Platinum complexes in cancer chemotherapy.

  1978cited by this paper
• Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.

  1978cited by this paper
• Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.

  1978cited by this paper
• Fluorescent labeling of hormone receptors in viable cells: preparation and properties of highly fluorescent derivatives of epidermal growth factor and insulin.

  1978cited by this paper
• Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.

  1977cited by this paper
• Current dilemmas in the management of non-seminomatous germ cell tumors of the testis.

  1977cited by this paper
• Cis-diamminedichloroplatinum (II). A new anticancer drug.

  1977cited by this paper
• Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.

  1977cited by this paper
• Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

  1977cited by this paper
• High dose Cis‐platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis

  1977cited by this paper
• The renal pathology in clinical trials of Cis‐platinum (II) diamminedichloride

  1977cited by this paper
• Noble metal complexes in cancer chemotherapy.

  1977cited by this paper
• Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.

  1976cited by this paper
• Cis-dichlorodiammineplatinum(II) in advanced bladder cancer.

  1976cited by this paper
• Clinical studies of Platinum Coordination compounds in the treatment of various malignant diseases.

  1975cited by this paper
• Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study.

  1973cited by this paper
• Clinical trials of cis-diamminedichloroplatinum (NSC-119875).

  1973cited by this paper
• Cis-dichlorodiammineplatinum (II). Persistent and selective inhibition of deoxyribonucleic acid synthesis in vivo.

  1970cited by this paper
• Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitro

  1970cited by this paper
• Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

  1965cited by this paper

• Dynamic Reconfiguration of Pt(II) Supramolecular Assemblies via Ligand Exchange

  2025cites this paper
• Intratympanic N-acetylcysteine in the prevention of cisplatin-induced ototoxicity: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Multimodal Treatment of Resectable Esophageal Cancer.

  2024cites this paper
• From the Discovery of Targets to Delivery Systems: How to Decipher and Improve the Metallodrugs’ Actions at a Molecular Level

  2023cites this paper
• Characterization of metal (Mg, Ni & Zn) complexes with β-sitosterol for antimicrobial studies

  2022cites this paper
• Canine Gastric Cancer: Current Treatment Approaches

  2022cites this paper
• Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers

  2021cites this paper
• Selected polyoxopalladates as promising and selective antitumor drug candidates

  2021cites this paper
• Combination Cancer Therapy of a Del1 Fragment and Cisplatin Enhanced Therapeutic Efficiency In Vivo

  2021cites this paper
• Comparisons of segment-specific toxicity of platinum-based agents and cadmium using S1, S2, and S3 cells derived from mouse kidney proximal tubules.

  2021cites this paper
• RSL3 enhances the antitumor effect of cisplatin on prostate cancer cells via causing glycolysis dysfunction.

  2021cites this paper
• Tissue-Specific Regulation of Reactive Oxygen Species by an ATP-Responsive Nanoregulator Enhances Anticancer Efficacy and Reduces Anthracycline-Induced Cardiotoxicity.

  2020cites this paper
• Biological Evaluation of Azo‐ and Imino‐Based Carboxylate Triphenyltin(IV) Compounds

  2020cites this paper
• Hyposalivation due to chemotherapy exacerbates oral ulcerative mucositis and delays its healing.

  2019cites this paper
• Inhibition of &agr;2C‐adrenoceptors ameliorates cisplatin‐induced acute renal failure in rats

  2018cites this paper
• The role of p53 status on the synergistic effect of CKD-602 and cisplatin on oral squamous cell carcinoma cell lines

  2018cites this paper
• Analysis and treatment of 45 platinum-allergic gynecologic malignant tumors

  2018cites this paper
• Characterizing metal-binding sites in proteins with X-ray crystallography

  2018cites this paper
• Isoliquiritigenin pretreatment attenuates cisplatin induced proximal tubular cells (LLC-PK1) death and enhances the toxicity induced by this drug in bladder cancer T24 cell line.

  2017cites this paper
• Unfolding biological properties of a versatile dicopper(II) precursor and its two mononuclear copper(II) derivatives.

  2017cites this paper
• 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules

  2016cites this paper
• Metal Based Compounds, Modulators of Na, K-ATPase with Anticancer Activity

  2016cites this paper
• Protective role of misoprostol against cisplatin-induced ototoxicity

  2016cites this paper
• The Effect of Dexpanthenol on Ototoxicity Induced by Cisplatin

  2016cites this paper
• Sulfonated Schiff base Sn(IV) complexes as potential anticancer agents.

  2016cites this paper
• Glyco-engineered horseradish peroxidase for targeted cancer treatment

  2015cites this paper
• Platinum hypersensitivity and desensitization.

  2015cites this paper
• Integrative analyses of genetic variation, epigenetic regulation, and the transcriptome to elucidate the biology of platinum sensitivity

  2014cites this paper
• Biometabolic Distribution of 99mTc-3PRGD2 and its Potential Value in Monitoring Chemotherapeutic Effects

  2014cites this paper
• The Role of Base Excision Repair and Mismatch Repair Proteins in the Processing of Cisplatin Interstrand Cross-Links

  2014cites this paper
• Protective effect of thymoquinone against cisplatin-induced ototoxicity

  2013cites this paper
• Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity.

  2013cites this paper
• Role of stem cell proteins and microRNAs in embryogenesis and germ cell cancer.

  2013cites this paper
• Síntese, caracterização e avaliação da atividade citotóxica de complexos de platina(II) e paládio(II) contendo hidrazonas

  2012cites this paper
• Genetic Variation That Predicts Platinum Sensitivity Reveals the Role of miR-193b* in Chemotherapeutic Susceptibility

  2012cites this paper
• Glioblastoma: Current Chemotherapeutic Status and Need for New Targets and Approaches

  2011cites this paper
• The role of apoptosis in cisplatin-induced ototoxicity in rats

  2009cites this paper
• Combination therapeutic effect of cisplatin along with Solanum trilobatum on benzo(a)pyrene induced experimental lung carcinogenesis

  2008cites this paper
• The Cell Protective Effects of Dioscoreae Rhizoma by Antioxidant Activities on HeLa Cells

  2008cites this paper
• Effect of Low Level Direct Current on in VivoTumor Growth in Hamsters1

  2006cites this paper
• The effect of captopril on renal function in patients during the first cis-diamminedichloroplatinum II infusion

  2004cites this paper
• Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin

  2004cites this paper
• Does parenteral magnesium sulfate have an antiemetic effect during chemotherapy with cis-platinum?

  2004cites this paper
• Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function

  2004cites this paper
• In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea

  2004cites this paper
• Prophylaxis against hypomagnesaemia induced by cis-platinum combination chemotherapy

  2004cites this paper
• Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin

  2004cites this paper
• Prevention of Cisplatin Ototoxicity Using Transtympanic N-Acetylcysteine and Lactate

  2004cites this paper
• Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II

  2004cites this paper
• Changes in the stria vascularis of the guinea pig due to cis-platinum

  2004cites this paper
• Concurrent cisplatin and radiotherapy in advanced head and neck cancer

  2003cites this paper
• Vitamin E Protection from/ Potentiation of the Cytogenetic Toxicity of Cisplatin in Swiss Mice

  2002cites this paper
• Potential Transmission of the Cytogenetic Effects of Cisplatin in the Male Germline Cells of Swiss Mice

  2000cites this paper
• Cytogenetic Toxicity of Cisplatin in Bone Marrow Cells of Swiss Mice

  2000cites this paper
• Concomitant cisplatin and radiationtherapy in advanced head and neck cancers:

  1999cites this paper
• Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathy

  1995cites this paper
• Cis-diamminedichloroplatinum (CDDP) therapy for brain metastasis of lung cancer

  1993cites this paper
• The effects of carbocisplatin and radiation on skin flap survival.

  1992cites this paper
• Effects of prolonged exposure to cisplatin on cytotoxicity and intracellular drug concentration.

  1992cites this paper
• Cisplatin as a radiosensitizer in clinical practice: a pilot study.

  1991cites this paper
• Cisplatin as a radiosensitizer in clinical practice: a pilot study.

  1991cites this paper
• Crossover study with cisplatin or carboplatin in advanced ovarian cancer.

  1990cites this paper
• Pathophysiologic Basis for Brain Tumor Chemotherapy

  1990cites this paper
• Cisplatin and nifedipine: synergistic antitumor effects against an inherently cisplatin-resistant tumor.

  1988cites this paper
• Nephrotoxicity and pharmacokinetics of cisplatinum in young and adult rats.

  1988cites this paper
• Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis

  1988cites this paper
• Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data.

  1987cites this paper
• Genotoxic effects of cisplatin in somatic tissue of Drosophila melanogaster

  1987cites this paper
• Primary pineal yolk sac tumor: ultrastructural and immunohistochemical features--case report.

  1986cites this paper
• Cancer chemotherapy in infants and children.

  1985cites this paper
• Effect of low level direct current on in vivo tumor growth in hamsters.

  1985cites this paper
• Nephrotoxicity of 1,1-diaminomethylcyclohexane sulphato platinum II (spiroplatin; TNO-6).

  1985cites this paper
• Therapeutic uses of trace elements.

  1985cites this paper
• The influence of verapamil on renal function in patients treated with cisplatin.

  1985cites this paper
• TNO‐6‐induced acute renal failure. A case report

  1985cites this paper
• 9 Therapeutic uses of trace elements

  1985cites this paper
• Preclinical studies identifying carboplatin as a viable cisplatin alternative.

  1985cites this paper
• Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies

  1984cites this paper
• Clinical Pharmacokinetics of Commonly Used Anticancer Drugs

  1983cites this paper
• In vivo studies on the antitumor effect of cis-dichlorodiammineplatinum(II) against transplantable ovarian adenocarcinoma cells of the rat.

  1983cites this paper
• Platinum Analogues: Criteria for Selection

  1983cites this paper
• The quantitation of sister chromatid exchanges in lymphocytes of cancer patients at intervals after cytotoxic chemotherapy.

  1983cites this paper
• Some effects of combination chemotherapy with cis‐platinum on renal function in patients with nonseminomatous testicular carcinoma

  1983cites this paper
• Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II).

  1983cites this paper
• Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effects.

  1983cites this paper
• The induction of chromosome aberrations by cis-platinum(II) diamminodichloride in Drosophila melanogaster.

  1983cites this paper
• Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors.

  1982cites this paper
• Bile as a source of potential reactive metabolites.

  1982cites this paper
• The cortitoxic effects of cis-platinum in the guinea pig

  1982cites this paper
• The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.

  1982cites this paper
• Cerebral Blindness in Association with cis-Platinum Chemotherapy for Advanced Carcinoma of the Fallopian Tube

  1982cites this paper
• Human tissue distribution of platinum after cis-diamminedichloroplatinum

  1982cites this paper
• The inhibition of renal ATPase by cisplatin and some biotransformation products.

  1982cites this paper
• Epileptic seizures associated with cisplatin administration.

  1982cites this paper
• Premelting phenomenon in DNA caused by the antitumor drug cis-dichlorodiammineplatinum

  1981cites this paper
• [Study of cipropride in the treatment of digestive disorders induced by anticancer chemotherapy. Double-blind study using metoclopramide].

  1981cites this paper
• [Progress in drug development. 14].

  1981cites this paper
• Haemolytic anaemia after cisplatin treatment.

  1981cites this paper
• Cytogenetic effects of cis-platinum(II)diamminedichloride in vivo.

  1981cites this paper
• Synthesizing activity and ultrastructural findings of human blood cells after incubation with cis-platinum "in vitro".

  1981cites this paper